These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32475910)
1. Detection of Abacavir-Induced Structural Alterations in Human Leukocyte Antigen-B*57 : 01 Using Phage Display. Shirayanagi T; Aoki S; Fujimori S; Watanabe K; Aida T; Hirasawa M; Kumagai K; Hoshino T; Ito K Biol Pharm Bull; 2020; 43(6):1007-1015. PubMed ID: 32475910 [TBL] [Abstract][Full Text] [Related]
2. Structural Elements Recognized by Abacavir-Induced T Cells. Yerly D; Pompeu YA; Schutte RJ; Eriksson KK; Strhyn A; Bracey AW; Buus S; Ostrov DA Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28686208 [TBL] [Abstract][Full Text] [Related]
3. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. Norcross MA; Luo S; Lu L; Boyne MT; Gomarteli M; Rennels AD; Woodcock J; Margulies DH; McMurtrey C; Vernon S; Hildebrand WH; Buchli R AIDS; 2012 Jul; 26(11):F21-9. PubMed ID: 22617051 [TBL] [Abstract][Full Text] [Related]
5. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome. Fodor J; Riley BT; Kass I; Buckle AM; Borg NA Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847 [TBL] [Abstract][Full Text] [Related]
6. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions]. Aoki S Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire. Illing PT; van Hateren A; Darley R; Croft NP; Mifsud NA; King S; Kostenko L; Bharadwaj M; McCluskey J; Elliott T; Purcell AW Front Immunol; 2021; 12():672737. PubMed ID: 34093574 [TBL] [Abstract][Full Text] [Related]
8. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation. Thomson PJ; Illing PT; Farrell J; Alhaidari M; Bell CC; Berry N; O'Neill PM; Purcell AW; Park KB; Naisbitt DJ Allergy; 2020 Mar; 75(3):636-647. PubMed ID: 31549414 [TBL] [Abstract][Full Text] [Related]
9. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950 [TBL] [Abstract][Full Text] [Related]
10. Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation. Naisbitt DJ; Yang EL; Alhaidari M; Berry NG; Lawrenson AS; Farrell J; Martin P; Strebel K; Owen A; Pye M; French NS; Clarke SE; O'Neill PM; Park BK AIDS; 2015 Nov; 29(18):2385-95. PubMed ID: 26372480 [TBL] [Abstract][Full Text] [Related]
11. Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine. Guo Y; Shi L; Hong H; Su Z; Fuscoe J; Ning B Sci China Life Sci; 2013 Feb; 56(2):119-24. PubMed ID: 23393027 [TBL] [Abstract][Full Text] [Related]
12. T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms. Bell CC; Faulkner L; Martinsson K; Farrell J; Alfirevic A; Tugwood J; Pirmohamed M; Naisbitt DJ; Park BK Chem Res Toxicol; 2013 May; 26(5):759-66. PubMed ID: 23541086 [TBL] [Abstract][Full Text] [Related]
13. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Martin AM; Krueger R; Almeida CA; Nolan D; Phillips E; Mallal S Pharmacogenet Genomics; 2006 May; 16(5):353-7. PubMed ID: 16609367 [TBL] [Abstract][Full Text] [Related]
14. Abacavir hypersensitivity reaction: an update. Hughes CA; Foisy MM; Dewhurst N; Higgins N; Robinson L; Kelly DV; Lechelt KE Ann Pharmacother; 2008 Mar; 42(3):387-96. PubMed ID: 18303141 [TBL] [Abstract][Full Text] [Related]
15. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity. Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412 [TBL] [Abstract][Full Text] [Related]
16. HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA Mounzer K; Hsu R; Fusco JS; Brunet L; Henegar CE; Vannappagari V; Stainsby CM; Shaefer MS; Ragone L; Fusco GP AIDS Res Ther; 2019 Jan; 16(1):1. PubMed ID: 30651100 [TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta. Berka N; Gill JM; Liacini A; O'Bryan T; Khan FM Hum Immunol; 2012 Feb; 73(2):164-7. PubMed ID: 22197535 [TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Chessman D; Kostenko L; Lethborg T; Purcell AW; Williamson NA; Chen Z; Kjer-Nielsen L; Mifsud NA; Tait BD; Holdsworth R; Almeida CA; Nolan D; Macdonald WA; Archbold JK; Kellerher AD; Marriott D; Mallal S; Bharadwaj M; Rossjohn J; McCluskey J Immunity; 2008 Jun; 28(6):822-32. PubMed ID: 18549801 [TBL] [Abstract][Full Text] [Related]
19. The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice. Song B; Aoki S; Liu C; Susukida T; Kuwahara S; Ito K Toxicology; 2021 Nov; 463():152971. PubMed ID: 34606953 [TBL] [Abstract][Full Text] [Related]